NCT02212327View on ClinicalTrials.gov

Testing Tissue Sodium Stores in CAPD Patients-Aims 1 & 2

CompletedOBSERVATIONAL
Enrollment

41

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

November 29, 2016

Study Completion Date

November 29, 2016

Conditions
End Stage Renal Disease
Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Vanderbilt University Medical Center

OTHER

NCT02212327 - Testing Tissue Sodium Stores in CAPD Patients-Aims 1 & 2 | Biotech Hunter | Biotech Hunter